← Back to Clinical Trials
Recruiting NCT06863649

NCT06863649 Short-term Effect of Using Non-immersive Gamified Exercises on Chronic Pain in People With Stroke.

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06863649
Status Recruiting
Phase
Sponsor University of Exeter
Condition Stroke Patients
Study Type OBSERVATIONAL
Enrollment 30 participants
Start Date 2025-03-01
Primary Completion 2025-07

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type OBSERVATIONAL
Interventions
Gamified NON-IMMERSIVE VIRTUAL REALITY EXERCISESvideo-based exercises

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 30 participants in total. It began in 2025-03-01 with a primary completion date of 2025-07.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Rehabilitation after stroke is essential to minimize permanent disability. Gamification of exercises has emerged as a promising strategy for increasing motivation and rehabilitation efficacy in people with stroke. However, there is a gap in understanding how exercise gamification can aid in pain management among people with stroke who are experiencing shoulder pain difficulties. This study aims to evaluate the short-term effect of using gamified non-immersive exercises on shoulder pain level, upper limb range of motion, and shoulder and elbow muscle activities while doing different activities in people with chronic stroke. The study will be conducted using an observational study design. Various lab assessments include measuring the ROM of the shoulder (MOCAP), EMG, FNIRS, pain intensity using VAS scale, and muscles activities patterns across upper limb joints.

Eligibility Criteria

Inclusion Criteria: * Experiencing motor difficulties in using the paretic arm, with some use of hand/arm as determined by therapist * Not participating any other intervention studies * Male/female ≥18 years old * Had a stroke requiring with any degree of arm mobility. * Capacity to consent to participate * Able to communicate adequately in English with the research team * Mild or moderate pain in shoulder or upper limb (below 6 and more than 2on the VAS scale). * Able to walk without any assistant at least for ten meters Exclusion Criteria: * Any medical condition compromising the safety or the ability to take part to the study as determined by the therapist (such as insufficient vision or hearing, upper limb condition not linked to stroke, uncontrolled blood pressure, uncontrolled diabetes, co-morbidity) * History of more than one epileptic seizures since stroke onset or uncontrolled epileptic seizure * Unable to follow two stage command * Moderate to severe hemi-spatial neglect compromising the ability to take part to the study, as determined by rehab team * Severe spasticity (more than 2 on the modified Ashworth scale) * Any device preventing use of EMG, FNIRS i.e. DBS or pacemaker

Contact & Investigator

Central Contact

Shaghayegh Nayebi

✉ sn506@exeter.ac.uk

📞 +447508489796

Principal Investigator

Helen Dawes

PRINCIPAL INVESTIGATOR

University of Exeter

Frequently Asked Questions

Who can join the NCT06863649 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Stroke Patients. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06863649 currently recruiting?

Yes, NCT06863649 is actively recruiting participants. Contact the research team at sn506@exeter.ac.uk for enrollment information.

Where is the NCT06863649 trial being conducted?

This trial is being conducted at Exeter, United Kingdom.

Who is sponsoring the NCT06863649 clinical trial?

NCT06863649 is sponsored by University of Exeter. The principal investigator is Helen Dawes at University of Exeter. The trial plans to enroll 30 participants.

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology